We predicted if CS1 was essential for CAR-T function, we would detect reduced survival and/or increased tumor burden in ΔCS1-BCMA-CAR-T treated mice compared to BCMA-CAR-T treated mice. The gene discussed is TNFRSF17; the disease is neoplasm.